Annual Report And Accounts

Overview

The report highlights Oxford Biomedica's successful manufacture of more than 100 million doses of the Oxford AstraZeneca COVID-19 vaccine. It also describes the transformational Homology transaction, which expanded the Group's capabilities into AAV manufacturing and established a US presence. The ESG report records 4,021 tCO~2~e of location-based emissions, a 2% decrease from the prior year, alongside TCFD disclosures and a net-zero commitment for 2040.

Document

Report type: Annual Report with Sustainability Disclosures
Class: Embedded
Scope: Full report
Fiscal year: 2021
Period: Ends 31 December 2021
Language: English
Pages
File size
Restatement: Disclosed

Reporting standards, commitments and assurance details are available with a free account.

Standards

GRI
SASB
TCFD
ISSB
ESRS
Integrated Reporting Framework
GHG Protocol
EU Taxonomy
CDP

Materiality

Assessment
Basis

Assurance

Statement included

Data Services

Turn sustainability reports into a dataset built for your research.

From bulk PDFs to structured indicators and machine-readable documents.

View services